DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Mato AR, Hill BT, Lamanna N. et al.
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Ann Oncol 2017;
28: 1050-1056
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.